Overview

The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of MK0859 on lipoprotein metabolism in patients with dyslipidemia already on statin therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Anacetrapib
Atorvastatin
Atorvastatin Calcium
Oxazolidinones